Evidence map

TrialFunction (Oxford, England)2025

Blockade of Angiotensin II Receptor Type 1 Abolishes the Erythropoietin Response to Exercise.

Meihan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40690272